The EMA has started a review of GSK's treatment candidate for primary biliary cholangitis (PBC), linerixibat, offering hope ...

GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.

EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Tuesday, June 24, 2025, 09:00 Hrs [IST] GSK plc announced ...

Lisa Woodcock's initial instinct when she first developed severe itching all over her body was to blame an allergic reaction ...

“If your itching is caused by a liver problem, there won’t be a skin rash or an insect bite,” the Liver Foundation says. The ...

FDA approves Ipsen's Iqirvo for primary biliary cholangitis, ending a 10-year hiatus in new therapies for the rare cholestatic liver disease.

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease.

THIS YEAR, the vibrant city of Amsterdam, the Netherlands played host to the European Association for the Study of ...

GSK said on Monday that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an investigational treatment for cholestatic pruritus in patients with ...

Elmore Leonard once said “I don’t have any of the modern electronics at all. I know the Internet would be a distraction. I ...

Researchers warned of worsening health outcomes and financial strain for the 2 million Americans with hepatitis C if the Supreme Court cancels free preventive care covered by the Affordable Care Act.

What Are the Treatment Options for Primary Biliary Cholangitis (PBC)? Side Effects of Rezdiffra: What You Need to Know. Read this next. Worried About Your Liver? Here’s What to Look For.